Frontlight ResearchEarly access
Trial site
MidAmerica Division Inc., c/o Research Medical Center
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Lung cancer2 trials
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Status
- Active, not recruiting3 trials
- Terminated2 trials
- Completed1 trial
- Lead sponsor
- Gilead Sciences3 trials
- Pfizer1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Shanghai Henlius Biotech1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Closed trials
Terminated
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026